PATENT CLAIM ANALYSIS

Application Number: 15746964
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-11
Patent Classification: ["514", "168000"]

Abstract:
The invention relates to new compounds with low cytotoxicity for blocking the ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of disorders including, but not limited to, cancers, neurodegenerative diseases, inflammatory disorders, autoimmune disorders and metabolic disorders.

Claim (Index 19):
The method of  claim 18 , wherein the inflammatory disorder or autoimmune disorder is restenosis, inflammation, rheumatoid arthritis, tissue injury due to inflammation, hyperproliferative diseases, severe or arthritic psoriasis, muscle-wasting diseases, chronic infectious diseases, abnormal immune response, conditions involving vulnerable plaques, injuries related to ischemic conditions, and viral infection or proliferation.

Metadata:
- Claim Count in Document: 30.0
- Percentile: 86.0
- Lexical Diversity: 1.36111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12555018', '12309459', '14790978', '13906626', '14592801']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.804196708391843
- 35 USC 102 Novelty (BERT): 0.5163463372658652
- Combined Prediction Score: 0.7754116712792452
- Mean Citation Score: 266.204172
- Max Citation Score: 272.8594
- Similarity Product: 168.74284992804527

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test